Zacks Investment Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
+64,181
New +$901K 0.01% 416
2024
Q4
Sell
-10,095
Closed -$325K 762
2024
Q3
$325K Sell
10,095
-1,660
-14% -$49K ﹤0.01% 543
2024
Q2
$280K Sell
11,755
-1,302
-10% -$33.4K ﹤0.01% 518
2024
Q1
$389K Buy
13,057
+3,055
+31% +$95.6K ﹤0.01% 507
2023
Q4
$320K Sell
10,002
-4,186
-30% -$121K ﹤0.01% 517
2023
Q3
$415K Hold
14,188
0.01% 472
2023
Q2
$638K Hold
14,188
0.01% 430
2023
Q1
$489K Buy
14,188
+20
+0.1% +$649 0.01% 454
2022
Q4
$395K Sell
14,168
-1,970
-12% -$52.2K 0.01% 467
2022
Q3
$378K Sell
16,138
-814
-5% -$26K 0.01% 457
2022
Q2
$490K Sell
16,952
-1,513
-8% -$66.1K 0.01% 435
2022
Q1
$1.02M Buy
18,465
+15
+0.1% +$742 0.01% 365
2021
Q4
$985K Buy
+18,450
New +$856K 0.01% 378

Other funds holding SGRY

Zacks Investment Management's SGRY Position: Q2 2026 in Review

Zacks Investment Management opened a new position in Surgery Partners (SGRY) in Q2 2026: 64,181 shares worth $1.08M. The stake represents 0.01% of the portfolio and ranks #416 among its holdings. This is a return to the name: Zacks Investment Management previously reported a position in SGRY as recently as Q3 2024.

Zacks Investment Management first reported a position in SGRY in Q4 2021 and has held it in 13 quarters since. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Zacks Investment Management held 64,181 shares of Surgery Partners worth $1.08M as of Q2 2026.
  • Surgery Partners was a new Zacks Investment Management position in Q2 2026.
  • Surgery Partners made up 0.01% of Zacks Investment Management's portfolio in Q2 2026, its #416 holding.
  • Zacks Investment Management first reported a position in Surgery Partners in Q4 2021 and has held it in 13 quarters since.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.